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Abstract
Background: Extracting biological knowledge from large amounts of gene expression information
deposited in public databases is a major challenge of the postgenomic era. Additional insights may
be derived by data integration and cross-platform comparisons of expression profiles. However,
database meta-analysis is complicated by differences in experimental technologies, data post-
processing, database formats, and inconsistent gene and sample annotation.
Results: We have analysed expression profiles from three public databases: Gene Expression
Atlas, SAGEmap and TissueInfo. These are repositories of oligonucleotide microarray, Serial
Analysis of Gene Expression and Expressed Sequence Tag human gene expression data
respectively. We devised a method, Preferential Expression Measure, to identify genes that are
significantly over- or under-expressed in any given tissue. We examined intra- and inter-database
consistency of Preferential Expression Measures. There was good correlation between replicate
experiments of oligonucleotide microarray data, but there was less coherence in expression
profiles as measured by Serial Analysis of Gene Expression and Expressed Sequence Tag counts.
We investigated inter-database correlations for six tissue categories, for which data were present
in the three databases. Significant positive correlations were found for brain, prostate and vascular
endothelium but not for ovary, kidney, and pancreas.
Conclusion: We show that data from Gene Expression Atlas, SAGEmap and TissueInfo can be
integrated using the UniGene gene index, and that expression profiles correlate relatively well
when large numbers of tags are available or when tissue cellular composition is simple. Finally, in
the case of brain, we demonstrate that when PEM values show good correlation, predictions of
tissue-specific expression based on integrated data are very accurate.
Background
High-throughput expression profiling is a major tool for
functional annotation of sequenced genomes. SAGEmap
[1] and NCI60 cDNA microarray [2] datasets have been
incorporated into the Ensembl and UCSC human genome
browsers. Large-scale expression data have also been used
to construct a transcriptional profile of adult skeletal mus-
cle [3]; to identify genes preferentially expressed in pros-
tate [4], granulocytes [5] and thyroid [6]; to discover
markers of pathological states such as cancer [7], and for
whole genome structure analysis such as identification of
clusters of similarly expressed genes [8,9].
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Numerous public databases have been created to store
large-scale expression data. These databases are, however,
heterogeneous in format, sample annotation, and statisti-
cal post-processing of experimental results. Furthermore,
the different databases store data from different experi-
mental technologies. A cross-platform comparison
between cDNA and oligonucleotide microarrays has dem-
onstrated that data generated by different platforms may
have poor correlation [10]. We investigated whether three
public gene expression databases: the Gene Expression
Atlas published by Su et al. [11], SAGEmap [1] and Tissue-
Info [12] (representing respectively oligonucleotide
microarray, Serial Analysis of Gene Expression – SAGE,
and Expressed Sequence Tags – ESTs) are internally con-
sistent and complementary when used to compare expres-
sion profiles of human genes within six normal tissue
categories, which were represented in the three databases.
The scope of this study is integration of expression data
and meta-analysis of datasets. Our aim is to evaluate the
congruence of publicly available expression datasets. It
was not our intention to provide a technical benchmark-
ing of different expression platforms, because such a
benchmarking exercise would require controlled microar-
ray, SAGE and EST experiments starting with identical
RNA samples derived from the same tissue specimen, and
would be beyond the resources of most laboratories.
Results and discussion
Preferential Expression Measure
We devised a Preferential Expression Measure (PEM) to
score differential expression of genes in tissues. PEM
describes the expression of a gene in a given tissue in rela-
tion to its expression in all tissues. Therefore, PEM con-
trols for the fact that some genes are highly expressed
across many tissues (housekeeping genes), and has the
virtue of reporting a negative value for under-expressed
genes, and a positive value for over-expressed genes. Large
positive PEM scores for a gene in a particular tissue indi-
cate that the gene is unusually highly expressed in that tis-
sue, relative to its expression in other tissues. Large
negative PEM scores indicate repression of a gene in a
tissue.
For SAGEmap and TissueInfo we define PEM as log10(o/e),
where o is the observed SAGE or EST tag count for a gene
in a given tissue, and e the expected tag count under the
null hypothesis of uniform expression in all tissues. e is
calculated as (G * N/T) where G is the total number of tags
ascribed to the gene, N is the total number of tags for the
tissue, and T is the total number of tags in the dataset.
For example, carbonic anhydrase XI (UniGene cluster
Hs.22777) is linked to a SAGE tag GTCGCTGAGA. This
tag occurs 132 times in all normal tissue SAGEmap librar-
ies. The total number of SAGE tags in the normal brain tis-
sue category is 326,481, and the total number of tags in all
normal tissue categories is 1,077,231. Therefore, if the dis-
tribution of this tag was uniform across all libraries, it
would be expected to occur ~40 times (132 * 326,481/
1,077,231) in brain libraries (expected count). The actual
count in brain libraries is 124 (observed count) bringing
the PEM value for this tag in brain to log10(o/e) =
log10(132/40) = 0.49.
For microarray experiments, where the raw data is a con-
tinuous variable (a relative intensity of a gene-specific flu-
orescent signal) as opposed to a tag count, we defined
PEM as log10(S/A), where S is the specific tissue signal for
a gene and A is the arithmetic mean signal for the gene
across all tissues.
Reproducibility and internal consistency
A major concern with all types of high-throughput expres-
sion data is reproducibility and internal consistency. To
investigate this, for each of the three databases, we com-
pared replicate experiments (where available) or equiva-
lent tissues and measured the Pearson correlation
coefficient for relative fluorescent signal intensity values
assigned to the same probe in a pair of experiments. Gene
Expression Atlas oligonucleotide microarray data had
good correlation between repeat hybridizations of the
same RNA sample (mean r2 = 0.94 ± 0.04; N = 45 pairwise
comparisons) and, as expected, slightly lower values for
repeat hybridizations of different RNA preparations from
the same tissue type (mean r2 = 0.87 ± 0.06; N = 17 pair-
wise comparisons).
Internal correlations for SAGEmap and TissueInfo were
lower. Counts of identical tags were correlated in pairwise
SAGEmap library comparisons yielding mean r2 values of
0.51 ± 0.25, N = 15 for brain; 0.26 ± 0.08, N = 6 for pros-
tate; 0.89, N = 2 for vascular endothelium; 0.27, N = 2 for
ovary; 0.83, N = 2 for kidney; and 0.97, N = 2 for pancreas.
For TissueInfo, we included tumour tissues to maximize
the size of datasets and, therefore, minimize the sampling
error. Counts of EST tags linked to the same UniGene clus-
ter in pools of libraries were correlated. Comparison of
brain TissueInfo libraries comprising 154,214 EST tags
from normal tissue and 111,317 from tumour tissue,
revealed an r2 of only 0.27.
Correlations among tissue profiles from Gene Expression 
Atlas, SAGEmap and TissueInfo
To compare different databases we grouped libraries into
higher-level tissue categories, and calculated Pearson cor-
relation coefficients for PEM scores for categories that
were represented in all three databases. Tumour tissue
libraries were not used in any of the interdatabaseBMC Genomics 2003, 4 http://www.biomedcentral.com/1471-2164/4/31
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Table 1: r2 values for Pearson correlations between PEM scores computed from Gene Expression Atlas (GEA), SAGEmap and 
TissueInfo expression profiles for six human tissue categories, for which data were available in the three databases.
Tissue TissueInfo vs. SAGEmap GEA vs. SAGEmap GEA vs. TissueInfo
Genesa r2 Pb Signsc Genesa r2 Pb Signsc Genesa r2 Pb Signsc
Brain 346 0.59 <0.01 92% 479 0.49 <0.01 84% 1431 0.43 <0.01 77%
Prostate 58 0.36 <0.01 76% 237 0.09 <0.01 59% 266 0.19 <0.01 63%
Vascular 
endothelium
13 0.29 0.6 92% 150 0.37 <0.01 73% 23 0.05 0.29 39%
Ovary 10 0.11 0.35 30% 175 0.03 0.2 49% 36 0.03 0.28 69%
Kidney 103 0.01 0.36 34% 140 0.00 0.78 50% 508 0.11 <0.01 55%
Pancreas 21 0.02 0.55 62% 141 0.00 0.59 48% 82 0.02 0.19 55%
a Number of genes compared. SAGEmap and TissueInfo data were only used for genes whose PEM scores were significant by χ2 test (P = 0.05), and 
only tags that could be mapped unambiguously to UniGene were used. b Two-tailed significance values for Pearson correlation coefficients. c 
Percentage of genes whose PEM scores have the same sign for the two methods being compared.
Correlations between the three databases Figure 1
Correlations between the three databases Correlations between Gene Expression Atlas (GEA), SAGEmap, and Tissue-
Info preferential expression measures (PEM) for brain, prostate and vascular endothelium. Trend lines for linear regression and 
the corresponding r2 values are shown for each pairwise comparison.
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comparisons. UniGene was used as the common gene
index to link entries from the three databases. There were
six tissues available for comparison (Table 1). Significant
positive correlations were found for brain, prostate and
vascular endothelium (Figure 1) but not for ovary, kidney,
and pancreas.
Because of sampling error, the total number of sequenced
tags is a key determinant of reliability of SAGE and EST
expression profiles. In our analysis, brain is the tissue cat-
egory with the highest number of both SAGE and EST tags
(Table 2) and accordingly shows the strongest correlations
of PEM values among oligonucleotide microarray,
SAGEmap, and TissueInfo (Table 1). Prostate, the tissue
category with the second highest total number of tags,
showed good correlation between SAGEmap and Tissue-
Info, but the correlation between the tag-based databases
and oligonucleotide microarray data was weaker (r2 of
0.09 and 0.19 for SAGEmap and TissueInfo respectively).
We suggest that the relative complexity of a tissue is
another important factor for comparison of high-through-
put expression profiles deposited in public databases.
Complex tissues consist of many cell types that may be
mixed in different proportions in different samples.
Expression profiles obtained from these tissues will be
heterogeneous and consequently require a large number
of tags and repeated hybridizations to detect signal in the
noise. This is shown by the relatively strong correlations
seen in SAGEmap/TissueInfo and SAGEmap/microarray
correlations for vascular endothelium despite the small
number of tags available (in comparison to brain, about
3-fold fewer SAGE tags and 18-fold fewer EST tags).
SAGEmap and dbEST/TissueInfo vascular endothelium
libraries are derived from in vitro cultures or homogenous
primary isolates of vascular endothelial cells [13].
Correlations of PEM scores obtained from the three data-
bases for kidney, pancreas, and ovary had very low r2 val-
ues (Table 1). However, measuring the correlation
coefficient of PEM scores is a very rigorous test of congru-
ence, because it not only requires that two datasets being
compared identify the same sets of genes as being over- or
under-expressed in the tissue, but also that the genes devi-
ate from uniform expression to a similar degree. This may
be an unrealistic expectation; for example, it is apparent
from Figure 1 that PEM scores for SAGEmap in brain
never exceed +1.19 (i.e., approximately 15-fold over-rep-
resentation), which is probably due to the limited size of
the SAGE database. A simpler test is to divide the plots
into quadrants and measure the fraction of genes for
which the two methods being compared give PEM scores
with the same sign. For example, for brain tissue the PEM
scores from SAGEmap and TissueInfo data are both posi-
tive for 134 genes, both negative for 184 genes, and in dis-
agreement for only 28 genes (i.e., one method identifies
the gene as significantly over-expressed in brain, and the
other identifies it as significantly under-expressed) (Figure
1). Across all six tissues and three datasets, the PEM signs
are in agreement for more than 50% of genes (the null
expectation) in 13 of the 18 comparisons made (Table 1).
Tissue-specific genes
We showed previously that integrating two expression
databases (SAGEmap and dbEST) provided accurate pre-
dictions of vascular endothelium-specific expression that
were verified experimentally, whereas neither method
alone was reliable [13]. Similarly, genes for which Gene
Expression Atlas, SAGEmap and TissueInfo analyses all
yield positive PEM scores should be very strong candi-
dates for being tissue-specific. To test this hypothesis, we
integrated PEM scores from the three types of expression
profile to search for putative brain-specific genes. The 50
top-scoring genes were investigated through LocusLink
and OMIM and of these 47 proved to be previously
known brain-specific or preferentially brain expressed
genes (Table 3). Three genes were novel, one of which was
highly similar to a known brain-specific inorganic phos-
phate co-transporter. This confirms the very high reliabil-
ity of integrated predictions of tissue-specific expression.
The bottom-scoring ten genes for brain are also listed in
Table 1. They have negative PEM values indicating under-
representation in the brain transcriptome. Four of these
genes are epithelial markers (EPCAM, KRT5, KRT18, and
KRT19).
The top ten prostate-specific genes are listed in Table 4. As
with the analysis for brain, combining Gene Expression
Atlas, SAGEmap and TissueInfo data appears to identify
prostate-specific genes successfully. Five genes were previ-
Table 2: Number of SAGE and EST tags in tissue categories derived from SAGEmap and TissueInfo.
Brain Prostate Kidney Vascular endothelium Ovary Pancreas
SAGE 326,481 150,116 67,923 110,460 96,911 64,577
EST 154,214 51,299 60,188 8,435 12,587 23,545
SAGE+EST 480,695 201,415 128,111 118,895 109,498 88,122BMC Genomics 2003, 4 http://www.biomedcentral.com/1471-2164/4/31
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Table 3: Top 50 brain-specific and bottom ten brain underexpressed genes (in italics) identified by integrated PEM scores from Gene 
Expression Atlas, SAGEmap and TissueInfo.
%PEM a UniGene cluster LocusLink symbol Description and references
76% Hs.6535 n/a novel cDNA clone, FLJ33742 fis, highly similar to Homo sapiens BNPI mRNA for brain-specific 
Na-dependent inorganic phosphate cotransporter (GenBank AK091061)
76% Hs.143535 CAMK2A calcium/calmodulin-dependent protein kinase, implied in control of fear and aggression [18]
75% Hs.78854 ATP1B2 ATPase, Na+/K+ transporting [19,20]
74% Hs.194301 MAP1A microtubule-associated protein, expressed strongly in brain, spinal cord and weakly in muscle 
[21]
73% Hs.84389 SNAP25 synaptosomal associated protein; one of SNARE proteins required for neuronal exocytosis 
[22]
72% Hs.2288 VSNL1 visinin like 1; known to be expressed in neuronal cells in retina [23]
72% Hs.1787 PLP1 lipophilin – the primary constituent of myelin [24]
72% Hs.296184 GNAO1 G protein alpha activating activity polypeptide O; multiple neurological abnormalities in knock-
out mice [25]; cloned from brain [26]
71% Hs.75819 GPM6A neuronal membrane glycoprotein M6A; similar to myelin proteolipid protein [27]
71% Hs.69547 MBP myelin basic protein [28]
70% Hs.74565 APLP1 amyloid beta (A4) precursor-like protein 1 [29]
69% Hs.6139 SYNGR1 synaptogyrin 1 [30]
69% Hs.154679 SYT1 synaptotagmin 1 [31]
68% Hs.20912 APCL brain-specific adenomatous polyposis coli (APC) homologue [32]
66% Hs.5422 GPM6B neuronal membrane glycoprotein M6B, highly similar to the myelin proteolipid protein [27]
66% Hs.79000 GAP43 neuromodulin, implied in axon guidance [33]
65% Hs.22777 CA11 carbonic anhydrase XI; brain-specific carbonic anhydrase isosyme [34]
65% Hs.239356 STXB1 syntaxin binding protein 1 [35]
65% Hs.182859 LFG lifeguard (alias neuromembrane protein 35) [36]
65% Hs.7979 SV2 synaptic vesicle glycoprotein 2 [37]
64% Hs.322430 NDRG4 ndrg family member 4, expressed in brain and heart [38]
64% Hs.74554 SYT11 synaptotagmin 11; identified by genomic screen with highly conserved synaptotagmin motif [39]
64% Hs.82749 TM4SF2 transmembrane 4 superfamily member 2; contains a trinucleotide repeat [40], implied in X 
linked mental retardation [41], implied in axon guidance
64% Hs.169401 APOE apolipoprotein E; implied in Alzheimer's disease [42]
63% Hs.166161 DNM1 dynamin 1 – brain expression at least 30-fold higher than in other tissues [43]
62% Hs.6164 NECL1 nectin-like protein 1; alias brain immunoglobulin receptor precursor (unpublished, GenBank 
NM_021189)
62% Hs.76888 INA internexin – neuronal intermediate filament protein alpha [44]
61% Hs.146580 ENO2 enolase 2 – neuronal-specific enolase [45]
61% Hs.90005 STMN2 stathmin-like 2; expressed in neuronal growth cones [46]
61% Hs.226133 GAS7 growth arrest-specific 7; expressed in neurons and growth-arrested fibroblasts [47]
60% Hs.155524 PNUTL2 septin 4; human orthologue of the mouse h5 brain protein [48]; involved in cell-division 
control; expressed in brain and, an alternatively spliced form, in heart [49]
60% Hs.117546 NNAT neuronatin; known to contain a 5' neurospecific silencer element which controls brain-specific 
expression [50]; possible role in brain development
60% Hs.155247 ALDOC brain-type aldolase; fructose-bisphosphate aldolase C [51]
60% Hs.7357 CLIPR-59 microtubule-binding protein involved in Golgi targeting; known to be preferentially expressed 
in brain [52]
60% Hs.74583 SPOCK2 sparc/osteonectin like; testican 2; calcium-binding proteoglycan specific to brain; expressed in 
many neuronal cell types in olfactory bulb, cerebral cortex, thalamus, hippocampus, 
cerebellum, and medulla [53]
60% Hs.80395 MAL hydrophobic integral membrane lipoprotein; a component of myelin [54]
60% Hs.6349 BC008967 novel protein BC008967
60% Hs.6755 RPIP8 RaP2 interacting protein; belongs to Ras family; expressed principally in brain [55]
60% Hs.75090 SPRING involved in synaptic exocytosis; expressed only in brain [56]
60% Hs.90063 NCALD neurocalcin delta; calcium-binding protein; expressed preferentially in brain [57]
58% Hs.83384 S100B calcium-binding protein S100; expressed in glia, astrocytes and neurons [58]
58% Hs.104925 ENC1 ectodermal-neural cortex; p53 induced gene; expressed preferentially in brain, particularly in 
amygdala and hippocampus [59]
58% Hs.7782 PNMA2 onconeuronal antigen MA2; expressed in brain and testis [60]
58% Hs.8526 B3GNT6 beta-1,3-N-acetylglucosaminyltransferase 6; expressed preferentially in foetal and adult brain 
[61]
56% Hs.125359 THY1 Thy-1 cell surface antigen; expressed in brain and on some T cells; neuronal expression pattern 
changes in development suggesting role in neurogenesis [62]BMC Genomics 2003, 4 http://www.biomedcentral.com/1471-2164/4/31
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ously known to be expressed specifically by prostate epi-
thelium (MSMB, ACPP, KLK3, AMD1 and RDH11). The
other five are muscle-specific genes. This is not unex-
pected since the fibromuscular stroma surrounding pros-
tatic glands is known to account for about half of the
volume of the prostate [14].
Conclusions
We show here that data from Gene Expression Atlas,
SAGEmap and TissueInfo can be integrated when libraries
are grouped into higher-level tissue categories and genes
are mapped between datasets using the UniGene gene
index. After integration, expression profiles between tis-
sue categories represented in multiple databases can be
compared using a measure of differential expression,
PEM. Internal consistency of PEM scores is high for Gene
Expression Atlas but poorer in the tissue categories
derived from SAGEmap and TissueInfo. Between datasets,
PEM values correlate relatively well when large numbers
of SAGE and EST tags are available (brain, prostate) or
when tissue cellular composition is simple (vascular
endothelium), but in the other tissue categories examined
the correlation is low. The usefulness of the integrated
dataset is demonstrated by the accuracy with which brain-
and prostate-specific genes could be identified. This sug-
gests that similar accuracy could be achieved for other tis-
sues if oligonucleotide microarray, SAGE, and EST
experiments were performed on RNAs from the same
well-annotated tissue samples of relatively simple cellular
composition. This would also enable direct comparison
and benchmarking of expression profiles obtained using
different technologies. The integrated dataset, code and
database schema are available on request from L.H.
Methods
Gene Expression Atlas
Affymetrix U95A oligonucleotide microarray [15] data for
12,587 consensus probes in 101 human tissue samples
were downloaded from the Gene Expression Atlas website
http://expression.gnf.org/data_public_U95.gz. Image
analysis and normalization has been performed using
Genechip 3.2 software (Affymetrix, Santa Clara, CA) by Su
et al. [11]. The libraries were grouped into 47 higher-level
tissue categories (averaging across duplicates and tripli-
cates). Tumour libraries were grouped as separate to nor-
mal tissues and not used for further analysis.
SAGEmap
Tag frequencies for 132 SAGEmap libraries [1] were
obtained from the project ftp site ftp://ftp.ncbi.nih.gov/
pub/sage. After downloading, the libraries were grouped
into 15 higher-level tissue categories (brain, prostate, kid-
56% Hs.194534 VAMP2 synaptobrevin 2; one of proteins involved in fusion of synaptic vesicles with the presynaptic 
membrane [63]
56% Hs.31463 ELMO1 engulfment and cell motility 1; orthologue of C. elegans gene ced-12; has two isforms – 4.4 kb 
expressed ubiquitously and 2.4 kb expressed only in brain [64]
55% Hs.3763 APBB1 amyloid beta (A4) precursor protein-binding; expressed preferentially in brain [65]
55% Hs.286055 CHN2 chimerin 2; expressed preferentially in cerebellum in granule cells [66]
55% Hs.12305 DKFZP566B183 novel protein DKFZP566B183
-50% Hs.80988 COL6A3 collagen type VI alpha 3 chain; type 3 alpha chain of a beaded filament collagen found in most 
connective tissues [67]
-50% Hs.79914 LUM lumican, a keratan sulfate proteoglycan known to be abundant in the corneal stroma and collagenous 
matrices of the heart, skeletal muscle, aorta, and intervertebral discs [68]
-51% Hs.38972 TSPAN-1 tetraspan 1 [69]
-53% Hs.692 EPCAM epithelial cellular adhesion molecule; expressed only on epithelial cells [70]
-56% Hs.297681 SERPINA1 antitrypsin, primarily expressed in liver [71]
-57% Hs.5372 CLDN4 claudin 4; expressed in kidney, small intestine, lung, heart, liver, and skeletal muscle; no expression was 
found in brain or spleen [72]
-57% Hs.81892 KIAA0101 identified in the Kazusa large-scale cDNA sequencing project [73]; northern blot revealed expression in 
many tissues but signal is completely absent from brain http://www.kazusa.or.jp/huge/gfpage/
KIAA0101/
-58% Hs.195850 KRT5 keratin 5; expressed in many epithelia including mammary epithelial cells and squamous epithelia 
lining the upper digestive tract [74]
-59% Hs.65114 KRT18 keratin 18  [75]; expressed in many epithelia
-60% Hs.182265 KRT19 keratin 19; found predominantly in the periderm – the transient layer that surrounds the developing 
epidermis [76]
a Integrated PEM score, calculated as the average of PEMGEA/PEMGEAmax, PEMSAGEMAP/PEMSAGEMAPmax, PEMTISSUEINFO/
PEMTISSUEINFOmax, where "max" refers to the maximum PEM value encountered in the tissue. This weighting scheme was used because brain 
microarray PEM values were several fold higher than those for SAGE and EST (PEMGEAmax = 5.21, PEMSAGEMAPmax = 1.19, PEMTISSUEINFOmax = 
1.15)
Table 3: Top 50 brain-specific and bottom ten brain underexpressed genes (in italics) identified by integrated PEM scores from Gene 
Expression Atlas, SAGEmap and TissueInfo. (Continued)BMC Genomics 2003, 4 http://www.biomedcentral.com/1471-2164/4/31
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ney, colon, pancreas, ovary, breast, skin, peritoneum,
stomach, blood, lung, liver, heart and vascular endothe-
lium) and annotated according to their disease status (91
tumour tissues, 37 normal tissue libraries and four
immortalised cell lines). Unless stated otherwise, only
normal tissue libraries (total of 1,077,231 tags) were used
for further analysis.
TissueInfo
The TissueInfo [12] database links ESTs from dbEST to the
tissue where there are expressed by assigning a tissue-key
to each EST entry. The dataset was downloaded from the
TissueInfo website http://icb.mssm.edu/tissueinfo/local-
inst.xml, which is updated daily, on 27 February 2002.
Our aim was to group EST into major tissues with suffi-
cient numbers of ESTs for statistically meaningful analy-
sis. Therefore, some TissueInfo categories were grouped
together into higher-level tissue categories. For example
hypothalamus was also annotated as brain. We excluded
ESTs that were annotated as mitochondrial libraries,
tumour libraries, or multiple tissues. This procedure
resulted in 48 higher-level tissue categories, 27 of which
had EST counts in excess of 10,000 (the number of ESTs
we accepted as the threshold for dataset size). We also
included vascular endothelium (8,435 ESTs) because of
the high number of SAGE tags available for this category
(110,460) and its simple cellular composition.
Mapping
Six higher-level tissue categories were available for com-
parison between Gene Expression Atlas, SAGEmap, and
TissueInfo (Table 1). An integrated MySQL database was
set up and gene identifiers from the UniGene gene index
were used to link expression data from the three datasets.
Only UniGene entries with more than one EST (62,008
entries) were considered as valid clusters. UniGene map-
ping was provided as part of both SAGEmap and Tissue-
Info datasets. To map oligonucleotide microarray probes,
probe consensus sequences were searched against longest
representative sequence of each UniGene cluster using
BLASTN with the cutoff parameter E = 10e-20. Alignments
were accepted if the percentage identity was higher than
94% and length was at least 99 bp or 90% of the length of
the query, or when percentage identity was 100% and
length more than 49 bp [11].
When linking UniGene clusters to SAGEmap data, Uni-
Genes mapping to more than SAGE tag sequence were
excluded (25% of clusters). The size of the Unigene data-
set linked to SAGEmap was, therefore, reduced from
21,224 to 15,872 clusters. Similarly, Unigene clusters
mapping to more than one Affymetrix probe were
excluded (22% of clusters). The size of the Unigene data-
set linked to Gene Expression Atlas data was, therefore,
reduced from 9,402 to 7,375 clusters. The overlaps
between UniGenes linked to GEA and SAGEmap, GEA
and TissueInfo, and SAGEmap and TissueInfo were 2742,
6758 and 15872 clusters respectively. Therefore:
- 63% and 8% of UniGene clusters linked to GEA could
not be linked to SAGEmap and TissueInfo respectively;
- 83% and 0% of UniGene clusters linked to SAGEmap
could not be linked to GEA and TissueInfo respectively;
- 74% and 89% of UniGene clusters linked to TissueInfo
could not be linked to SAGEmap and GEA respectively.
Statistics
Gene expression can be estimated by counting gene-spe-
cific SAGE and EST tags but, as a stochastic process, these
estimates are subject to sampling error. The size of the
sampled dataset can have a dramatic influence on reliabil-
ity of the data. Two independent groups have established
Table 4: Top ten prostate-specific genes identified by integrated PEM scores from Gene Expression Atlas, SAGEmap and TissueInfo.
%PEM a UniGene cluster LocusLink symbol Description and references
95% Hs.183752 MSMB beta microseminoprotein; synthesized by the epithelial cells of the prostate gland and 
secreted into the seminal plasma [77]
94% Hs.1852 ACPP prostatic acid phosphatase [78]
82% Hs.171995 KLK3 kallikrein 3; prostate specific antigen (PSA) [79]
73% Hs.78344 MYH11 smooth muscle-specific myosin heavy polypeptide 11 [80]
70% Hs.300772 TPM2 tropomyosin 2 (beta); binds actin [81]
55% Hs.195464 FLNA filamin A; binds actin [82]
54% Hs.75777 TAGLN transgelin; smooth muscle-specific actin binding protein [83]
53% Hs.262476 AMD1 S-adenosylmethionine decarboxylase 1; key enzyme in the synthesis of seminal 
polyamines such as spermine, spermidine [84]
53% Hs.9615 MYL9 myosin, smooth muscle-specific regulatory light polypeptide 9 [85]
48% Hs.179817 RDH11 androgen-regulated short-chain dehydrogenase/reductase 1 [86]
a Prostate PEMGEAmax = 4.30, PEMSAGEMAPmax = 1.97, and PEMTISSUEINFOmax = 1.61BMC Genomics 2003, 4 http://www.biomedcentral.com/1471-2164/4/31
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χ2 as the best statistical test to use in tag sampling experi-
ments [16,17]. We excluded from subsequent compara-
tive analysis all tissue/gene data for which the expected
number of tags (e) was less than 5, which is the lower limit
of reliability for the χ2 statistic. We used χ2 to filter the
PEM score for both tag-based methods: unless signifi-
cantly different from expectation (with P = 0.05) we con-
cluded that we had no confidence in either the sign or the
magnitude of the apparent deviation from uniform
expression. A relatively low significance threshold of 0.05
was used to maximize the number of values available for
inter-database comparison. Because χ2 test is only used on
a case-by-case basis for preliminary selection of informa-
tive datapoints, a multiple testing correction such as Bon-
ferroni correction was not applicable.
To compare the results from any two databases for a given
tissue, we plotted the PEM scores for all genes for which
data was available from the two experiments, but exclud-
ing SAGE and EST data with non-significant χ2. We calcu-
lated the correlation coefficient (r) and report r2, which
represents the proportion of the variability in the data that
is explained by the correlation.
Database versions
Gene Expression Atlas, Affymetrix human Genechip U95A
http://expression.gnf.org
SAGEmap, January 2002 http://www.ncbi.nlm.nih.gov/
SAGE/
TissueInfo, 27 February 2002 http://icb.mssm.edu/crt/tis
sueinfowebservice.xml
UniGene, Build 148 http://www.ncbi.nlm.nih.gov/Uni
Gene/
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